Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07105020

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

This trial is aimed to better understand the impact of migration history on the quality of life of Black immigrant CaP survivors (both SSAI and CI). We will illuminate the full range of racial, social, environmental, behavioral, and structural factors associated with the Black immigrant experience in the US using a SDOH model.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, 77030, United States

Location contact

Lorna McNeill, MPH,PHD

CONTACT

[email protected]

(713) 563-1103

Lorna McNeill, MPH,PHD

PRINCIPAL_INVESTIGATOR

About this study

Primary Objective:

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • be male adults (≥18 years old)
  • Self-identify as CI and SSAI
  • Self-identify as Black or African American
  • Have been diagnosed with CaP within the last 10 years
  • Have a U.S. address
  • Can read and write in English

Exclusion criteria

  • None

Treatment and study plan

Interviews

Behavioral

Interviews will be conducted in person, over the phone, or via Zoom.

Primary outcomes

  1. Safety and Adverse Events (AEs)

    Time frame: Through study completion; an average of 1 year

    Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Study contacts

Contact information is provided by the study sponsor or research team.

Lorna McNeill, MPH,PHD

CONTACT

[email protected]

(713) 563-1103

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2028
First posted
Aug 5, 2025
Registry last updated
Oct 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.